Ozempic and similar weight loss drugs may lower risk of 42 health conditions, but also pose risks

Several years ago, a little-known drug named Ozempic – previously used only to treat diabetes – emerged as a promising new drug for weight management. The Food and Drug Administration’s…

Off-brand Ozempic, Zepbound and other weight loss products carry undisclosed risks for consumers

In just a few years, brand-name injectable drugs such as Ozempic, Wegovy, Mounjaro and Zepbound have rocketed to fame as billion-dollar annual sellers for weight loss as well as to…

BMI alone will no longer be treated as the go-to measure for weight management – an obesity medicine physician explains the seismic shift taking place

Amid the buzz around weight loss drugs and rising rates of obesity worldwide, many health care professionals are questioning one of the key measures that has long been used to…